DRRX(Delisted)
DurectยทNASDAQ
--
--(--)
DRRX Profile
Durect Corporation
A company that developing pharmaceuticals for chronic pain and central nervous system disorders
10240 Bubb Road, Cupertino, CA 95014
--
Durect Corporation was incorporated in Delaware on February 6, 1998. The Company is a biopharmaceutical company and its R&D programs are broadly divided into two categories: (i) new chemical entities derived from the Company's epigenetic modulator program, in which the Company attempts to discover and develop molecules that have not previously been approved and marketed as therapeutic agents, and (ii) drug delivery programs, in which the Company's formulation expertise and technology are primarily applied to active pharmaceutical ingredients whose safety and efficacy have been previously identified but are intended to be improved in some way through new formulations. The company also manufactures and sells osmotic pumps for laboratory research and design, and develops and manufactures a wide range of standard and custom degradable polymers and excipients for pharmaceutical and medical device customers as raw materials in products.
